Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01645852 · ClinicalTrials.gov registry record · NA
A Phase II Study of the Effect of a Low Calorie Diet on Patients Undergoing Liver Resection
A NA study, sponsored by Dartmouth-Hitchcock Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 65
- Enrollment target
NCT01645852 is a NA study that has completed, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 65 participants.
The verdict
NCT01645852, a NA study, has completed, sponsored by Dartmouth-Hitchcock Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 65 participants
- Enrollment target
Study Summary
The purpose of this study is to measure the effect of a short-term low calorie diet on patients with a Body Mass Index (BMI) over 25 who are undergoing liver surgery.
Interventions
- DIETARY_SUPPLEMENT Optifast 800
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 2012-06 |
| Est. Completion | 2016-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01645852
The ClinicalTrials.gov registry entry for NCT01645852 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 65 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dartmouth-Hitchcock Medical Center, which has 427 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Optifast 800 is the first listed.
NCT01645852 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01645852 about?
NCT01645852 is a clinical study titled "A Phase II Study of the Effect of a Low Calorie Diet on Patients Undergoing Liver Resection". The purpose of this study is to measure the effect of a short-term low calorie diet on patients with a Body Mass Index (BMI) over 25 who are undergoing liver surgery.
What is the current status of trial NCT01645852?
This trial is currently completed. It is a NA study. The enrollment target is 65 participants. The study started on 2012-06. Estimated completion is 2016-12.
What interventions are being tested in trial NCT01645852?
The interventions under investigation include: Optifast 800 (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01645852?
This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.